Dramatic response of surface contact dermatitis to new parenteral corticosteroid-betamethasone sodium phosphate.
D000293:Adolescent; D000328:Adult; D001623:Betamethasone / Q000008:administration & dosage* / Q000031:analogs & derivatives / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003877:Dermatitis, Contact / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D010919:Placebos
D010919:Placebos; D001623:Betamethasone